Navigation Links
Matrixx Initiatives, Inc. to Present at the Roth Capital Partners 2007 New York Conference
Date:8/30/2007

(TM); Zicam Kids Size Cold Remedy Swabs(TM); Zicam Extreme Congestion Relief; Zicam Sinus Relief; Zicam Sinus RapidMelts(TM), as well as Zicam Cough products and Zicam Multi-Symptom relief items. For more information regarding Matrixx products, go to http://www.Zicam.com . To find out more about Matrixx Initiatives, Inc. (Nasdaq: MTXX), visit our website at http://www.matrixxinc.com. For additional information, contact William Hemelt, Chief Financial Officer, 602-385-8888, or Bill Barba, Treasurer, at 602-385-8881. Matrixx is located at 4742 N. 24th Street, Suite 455, Phoenix, Arizona 85016.

About the Roth Capital Partners 2007 New York Conference

Since 1984, Roth Capital Partners has been a leader and innovator in the small and micro cap markets. Roth provides the full spectrum of investment banking services, including raising capital, research coverage, creating liquidity, trading and market making, merger and acquisition advisory services, sales support, and investor conferences. Visit http://www.rothcp.com for more information.


'/>"/>
SOURCE Matrixx Initiatives, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Direct the strengths of traditional healers into Anti-AIDS initiatives, says WHO
2. Surgeons Presented Guidelines For Postoperative Atrial Fibrillation
3. Researchers Present Ways To Reduce The Risk Of Dementia
4. Researchers Present Data Regarding The Efficiency Of Herbs
5. Critically Ill Patients More At Risk Of Infection If Glucose Is Present In Their Lung Secretions
6. Ovarian Cancer Presents ‘Target Symptoms’ Six Months Before Diagnosi
7. Drug Reactions First Present Themselves In The Mouth
8. Reminiscing Into The Past Makes You Dissatisfied With The Present
9. Living In The Past Indicates Dissatisfaction With Present
10. Movies Represent Coma In A Wrong Way
11. Onchocerciasis: Presentation And Treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2008)...ough the number of jobs created in the medical fie...ed a different kind of slowdown: they laid off few... Seattle, WA (PRWEB) July 25, 2...dical field slowed in June overall, pharmaceutical...hat will be music to the ears of sales representat...
(Date:7/25/2008)...f Marketing Exclusivity Begins -, CORONA, Calif.,...uticals, Inc. (NYSE: WPI ), a leading specialty p...bsidiary has commenced commercial,shipment of its ... the 40mg,strength from its Davie, Florida manufac...atson has 180 days of marketing exclusivity for be...
(Date:7/25/2008)...5 /PRNewswire/ -- Sagent Pharmaceuticals, Inc.,a ...oday announced that it,has launched amiodarone HCl...ted for the treatment and prophylaxis of frequentl...ically unstable ventricular,tachycardia -- a poten...nt,s amiodarone HCl injection will be available im...
(Date:7/25/2008)...5 /PRNewswire/ -- AutoGenomics, Inc. today,announc...orm S-1 with the,Securities and Exchange Commissio... of shares of its common stock. The number of shar... expected to be offered by,AutoGenomics, Inc., and...en,determined., J.P. Morgan Securities Inc. is ac...
Breaking Medicine News(10 mins):Health News:The MedZilla Report: June 2008 Employment Outlook for Biotech/Pharma/Health 2Health News:The MedZilla Report: June 2008 Employment Outlook for Biotech/Pharma/Health 3Health News:Watson Launches Omeprazole Delayed-Release Capsules, 40MG 2Health News:Sagent Pharmaceuticals Launches Amiodarone HCl Injection, USP 2Health News:Sagent Pharmaceuticals Launches Amiodarone HCl Injection, USP 3Health News:AutoGenomics, Inc. Files Registration Statement for Initial Public Offering 2
...vouch for the difficulty of capturing a clear pict...es, however, sometimes the motion is exactly what ...d the pathological protein mis-folding and assembl... a host of human disorders, including diabetes and...
...merican research, there is still hope for the couc...urch, director of the Laboratory of Preventive Med...ch Center at Louisiana State University, shows tha...d daily exercise dose, a substantial and immediate...
... the outrage over an insensitive caption for the p...lia, comes the news that a pre-schooler was found...al for unwanted babies. The drop-off was opened b...e southern city of Kumamoto to discourage abortion...
...g Administration (FDA) today approved Evicel Fibri...cally helps control oozing from small blood vesse...n effective means to stop oozing from small vessel...ring, compression or other standard techniques are...
Other Medicine News:Health News:Decoding Protein Structures Helps Illuminate Cause of Diabetes 2Health News:Spare Just Ten Minutes A Day For A Healthier Heart 2Health News:Three-year-old Abandoned in Box Meant for Unwanted Babies in Japan 2
(Date:7/24/2008)...eeds Oncology Patient Accrual, DENVER, July 24 /P...ent,Organization (RMO), has contracted with five l...h and site management services for their,clinical ...ategy. The new,trials include the following diseas...Metastatic Breast Cancer, Metastatic Sarcoma, Chro...
(Date:7/23/2008)...in July print edition of Clinical ...uly 23 /- A Roche Diagnostics-sponsor...o-B-type natriuretic peptide,(NT-proBNP) confirms ...cation in predicting the risk of cardiovascular ad...steroidal anti-inflammatory drugs of,the COX inhib...
(Date:7/23/2008).../ -- InCode BioPharmaceutics, Inc.,an emerging bi...al test,results demonstrating the utility of their...e rare chronic blood disorder paroxysmal nocturnal...e presented at the XXII,International Complement W..., The only treatment currently available for PNH ...
(Date:7/22/2008)...-- Nonin Medical, a leading innovator,of physiolog...has entered,the clinical testing phase with its br...aturation. Today,s most common application for thi...egional blood oxygenation,in the brain -- cerebral...an ongoing clinical study at the,Duke University M...
Breaking Medicine Technology:Pharmatech, Inc. Contracts for Five New Just-in-Time Clinical Trials 2Study Reveals Potential for NT-proBNP as a Marker to Predict Cardiovascular Risks From Anti-Inflammatory Drugs 2Study Reveals Potential for NT-proBNP as a Marker to Predict Cardiovascular Risks From Anti-Inflammatory Drugs 3Study Reveals Potential for NT-proBNP as a Marker to Predict Cardiovascular Risks From Anti-Inflammatory Drugs 4InCode BioPharmaceutics, Inc. Announces Key Data Supporting New Treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH) 2Nonin Medical Inc. Announces Entry Into the Cerebral Oximeter Market 2Advanced Energy Consortium will develop micro and nanosensors to boost energy production 2605 1Advanced Energy Consortium will develop micro and nanosensors to boost energy production 2605 2Pelosi Democrats Host Health Care Forum This Morning 9587 1Pelosi Democrats Host Health Care Forum This Morning 9587 2Pelosi Democrats Host Health Care Forum This Morning 9587 3Pelosi Democrats Host Health Care Forum This Morning 9587 4Wisconsin Physicians Service Insurance Corporation Files Suit Against Aurora Health Care and HealthEOS 9583 1Wisconsin Physicians Service Insurance Corporation Files Suit Against Aurora Health Care and HealthEOS 9583 2The Widener University Elder Pennsylvanian Survey Finds Pennsylvanias Baby Boomers Anticipate Working Longer Retiring Later to Help Offset Looming He 9579 1The Widener University Elder Pennsylvanian Survey Finds Pennsylvanias Baby Boomers Anticipate Working Longer Retiring Later to Help Offset Looming He 9579 2The Widener University Elder Pennsylvanian Survey Finds Pennsylvanias Baby Boomers Anticipate Working Longer Retiring Later to Help Offset Looming He 9579 3The Widener University Elder Pennsylvanian Survey Finds Pennsylvanias Baby Boomers Anticipate Working Longer Retiring Later to Help Offset Looming He 9579 4
...nce of Recurrent Wheeze by,Almost Half, ABBOTT PAR...wswire-FirstCall/ -- Abbott and MedImmune today an...uly issue of Journal of,Pediatrics, showing that t...recurrent wheezing in premature infants by almost,...ure infants without,chronic lung disease who recei...
...Myeloma Workshop held in,Kos, Greece demonstrates ...h bortezomib, dexamethasone and lenalidomide plus,...y multiple,myeloma, and as a single agent in patie...obulinemia, NEW YORK, June 29, 2007 /PRNewswire-Fi...nnounced that 4 posters were,presented at the 11th...
Other Medicine Technology:New Study in Journal of Pediatrics Suggests Synagis (Palivizumab),May Reduce Subsequent Recurrent Wheezing in Preterm Infants 2New Study in Journal of Pediatrics Suggests Synagis (Palivizumab),May Reduce Subsequent Recurrent Wheezing in Preterm Infants 3New Study in Journal of Pediatrics Suggests Synagis (Palivizumab),May Reduce Subsequent Recurrent Wheezing in Preterm Infants 4New Study in Journal of Pediatrics Suggests Synagis (Palivizumab),May Reduce Subsequent Recurrent Wheezing in Preterm Infants 5Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase,II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple,Myeloma and Waldenstrom's Macroglobulinemia 2Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase,II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple,Myeloma and Waldenstrom's Macroglobulinemia 3Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase,II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple,Myeloma and Waldenstrom's Macroglobulinemia 4Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase,II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple,Myeloma and Waldenstrom's Macroglobulinemia 5Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase,II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple,Myeloma and Waldenstrom's Macroglobulinemia 6Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase,II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple,Myeloma and Waldenstrom's Macroglobulinemia 7
...te Focus from Thermo Labsystems was designed speci...performance. Advanced features such as the new fa...n microvolumes help to define this as a new leader...le handle plate offers a custom fit for different ...
...igital offers improved ergonomics for today's exac...fied grippy finger rest and the large display wind...ipette Digitals also feature soft-touch tip ejecti....) and super blow-out for 0.2 - 50ul micro volume ...
...els cover the range from 2ul to 5000ul. Fills and...prevents inadvertent volume change. Novel hand gr...te is autoclavable at 121C(250F). To prevent corr...ble for one-handed operation. Auto or Normal trig...
...pettor is the #1 Pipettor for sub-microliter pipet...iability. Continuously adjustable. Features lPLUS,...ter. Easy interchangeable ejector buttons to fit l...ip ejector with three different lengths. Air-displ...
Medicine Products: